These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32251737)

  • 1. Eosinophils in COPD-Current Concepts and Clinical Implications.
    Mycroft K; Krenke R; Górska K
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2565-2574. PubMed ID: 32251737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
    Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
    Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Eosinophilic chronic obstructive pulmonary disease: A review].
    Anaev EK
    Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J; Chen B; Wu S; Wu F
    BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic obstructive pulmonary disease (COPD): eosinophilia and novel drug therapies].
    Biener L; Pizarro C; Skowasch D
    Inn Med (Heidelb); 2024 Jul; 65(7):738-745. PubMed ID: 38831048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD.
    Antus B; Paska C; Barta I
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2025-2035. PubMed ID: 32921998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
    Greulich T; Hohlfeld JM; Neuser P; Lueer K; Klemmer A; Schade-Brittinger C; Harnisch S; Garn H; Renz H; Homburg U; Renz J; Kirsten A; Pedersen F; Müller M; Vogelmeier CF; Watz H
    Respir Res; 2018 Apr; 19(1):55. PubMed ID: 29615049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.
    Kostikas K; Brindicci C; Patalano F
    Curr Drug Targets; 2018; 19(16):1882-1896. PubMed ID: 29437007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma.
    Li A; Chan HP; Gan PXL; Liew MF; Wong WSF; Lim HF
    Korean J Intern Med; 2021 Nov; 36(6):1305-1319. PubMed ID: 34634855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic airway inflammation in COPD.
    Saha S; Brightling CE
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):39-47. PubMed ID: 18046901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood eosinophils in COPD: friend or foe?
    Papaporfyriou A; Bakakos P; Hillas G; Papaioannou AI; Loukides S
    Expert Rev Respir Med; 2022 Jan; 16(1):35-41. PubMed ID: 34821191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-bronchodilator Reversibility of FEV
    Chou KT; Su KC; Hsiao YH; Huang SF; Ko HK; Tseng CM; Su VY; Perng DW
    Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
    Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
    Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD treatment choices based on blood eosinophils: are we there yet?
    Oliver B; Tonga K; Darley D; Rutting S; Zhang X; Chen H; Wang G
    Breathe (Sheff); 2019 Dec; 15(4):318-323. PubMed ID: 31803266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
    Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A
    Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
    Pavord ID; Lettis S; Anzueto A; Barnes N
    Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease.
    Eltboli O; Mistry V; Barker B; Brightling CE
    Respirology; 2015 May; 20(4):667-70. PubMed ID: 25645275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.